- 201. Identity Reliability Code
- (UMLS (HL7) C1547825) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Patient/Person Name is an Alias;
Unknown/Default Address;
Unknown/Default Date of Birth;
Unknown/Default Social Security Number | - 251. IFF/MTX/PCB
- (UMLS (NCI) C0071973) =Therapeutic or Preventive Procedure ;
|
- 202. Ideographic
- [Ideographic representation of name (e.g., Japanese kanji, Chinese characters) ( HL7V3.0 )] (UMLS (HL7) C1553382) =Idea or Concept =NameRepresentationUse;
| - 252. IFF/TAX
- (UMLS (NCI) C0281335) =Therapeutic or Preventive Procedure
|
- 203. Ideographic (i.e., Kanji)
- (UMLS (HL7) C1547501) =Idea or Concept =Name/address representation;
| - 253. IFF/TOPO
- (UMLS (NCI) C0677972) =Therapeutic or Preventive Procedure
|
- 204. IDIO HYPERSOM-LONG SLEEP
- [ ] (UMLS (ICD9CM) C1561854) Idiopathic hypersomnia with long sleep time;
=Disease or Syndrome | - 254. IFF/VNB
- [A regimen consisting of ifosfamide and vinorelbine used for the treatment of relapsed or refractory Hodgkin's lymphoma. ( NCI )] (UMLS (NCI) C0281748) =Therapeutic or Preventive Procedure
|
- 205. IDIO HYPERSOM-NO LNG SLP
- [ ] (UMLS (ICD9CM) C1561855) Idiopathic hypersomnia without long sleep time;
=Disease or Syndrome | - 255. IFITM1
- [This gene is involved in the regulation of cell growth and proliferation. It also plays a role in immunity/defense. ( NCI )] (UMLS (NCI) C1334078) IFITM1 Gene;
Interferon Induced Transmembrane Protein 1 (9-27) Gene;
=Gene or Genome ;
|
- 206. IDIO PERIPH NEURPTHY NEC
- [ ] (UMLS (ICD9CM) C0154757) =Disease or Syndrome
| - 256. IFN
- [a group of proteins elaborated by infected host cells that protect noninfected cells from viral infection. ( CSP )] (UMLS (CSP) C0021747) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[IM700] IMMUNE STIMULANTS;
gene product;
Cytokine;
=IFNa;
Beta Interferon;
Gamma Interferon;
Interferon Type I;
IFN alpha-2B;
INTERFERON GAMMA-1B;
IFN Alfacon-1;
|
- 207. IDIO PERIPH NEURPTHY NOS
- [ ] (UMLS (ICD9CM) C0041848) =Disease or Syndrome ;
| - 257. IFN Alfacon-1
- [An analogue of consensus interferon which contains an additional methionyl amino acid residue. Consensus interferon (also known as interferon alfacon-1, rCon-IFN, and CIFN) is a genetically engineered synthetic interferon created from the most common amino acid sequences from the naturally occurring alpha interferons. Alpha interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. ( NCI )] (UMLS (NCI) C0164613) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=IFN alpha-2B;
IFN =interferon alfacon-1 0.03 MG/ML;
INTERFERON ALFACON-1 15 MCG/0.5ML;
|
- 208. IDIO PROG POLYNEUROPATHY
- [ ] (UMLS (ICD9CM) C0154756) =Disease or Syndrome
| - 258. IFN alpha-2B
- [A non-glycosylated recombinant interferon with antiviral and antineoplastic activities. Alfa interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products mediate antiviral, antiproliferative, anticancer, and immune-modulating effects. ( NCI )] (UMLS (NCI) C0021735) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =[IM700] IMMUNE STIMULANTS;
IFNa;
Interferon Type I, Recombinant;
IFN alpha-2B;
IFN;
TO BE DELETED INGREDIENT PREPARATIONS =INTERFERON GAMMA-1B;
IFN Alfacon-1;
PEGINTERFERON;
INTERFERON ALFA 2-B 18 MILLION UNT/VIL;
INTERFERON ALFA 2-B 3 MILLION UNT/VIL;
IFN alpha-2B;
Interferon Alfa-2b 50000000 UNT/ML;
Interferon Alfa-2b 18000000 UNT;
INTERFERON ALFA-2B,RECOMBINANT 10 MILLION UNT/SYR;
INTERFERON ALFA-2B,RECOMBINANT 3MILLION UNT/0.2ML;
INTERFERON ALFA-2B,RECOMBINANT 5 MILLION UNT/SYR;
INTERFERON ALFA-2B,RECOMBINANT 5MILLION UNT/0.2ML;
INTERFERON ALFA-2B,RECOMBINANT 6X3MIL U;
INTERFERON ALFA-2B,RECOMBINANT 50MILLION UNT;
INTERFERON ALFA-2B,RECOMBINANT 10 MILLION UNT/VIL;
INTERFERON ALFA-2B,RECOMBINANT 18 MILLION UNT/VIL;
INTERFERON ALFA-2B,RECOMBINANT 25MILLION UNT;
INTERFERON ALFA-2B,RECOMBINANT 5MILLION UNT;
INTERFERON ALFA-2B,RECOMBINANT 3MILLION UNT;
|
- 209. IDIOPATH AUTO NEUROPATHY
- [ ] (UMLS (ICD9CM) C0154690) =Disease or Syndrome ;
| - 259. IFN-A/IFN-G
- (UMLS (NCI) C0338119) =Therapeutic or Preventive Procedure ;
|
- 210. IDIOPATH SLEEP HYPOVENT
- [ ] (UMLS (ICD9CM) C1561864) Idiopathic sleep related nonobstructive alveolar hypoventilation;
=Disease or Syndrome | - 260. IFN-A/IL-12
- (UMLS (NCI) C0796319) Interferon Alfa/Interleukin-12;
=Therapeutic or Preventive Procedure |
- 211. IDIOPATHC TRANS MYELITIS
- [ ] (UMLS (ICD9CM) C1719404) Idiopathic transverse myelitis =Disease or Syndrome ;
| - 261. IFN-A/IL-2
- (UMLS (NCI) C0338121) =Therapeutic or Preventive Procedure ;
|
- 212. idiopathic
- [Describes a disease of unknown cause. ( NCI )] (UMLS (NCI) C0332240) =Functional Concept
| - 262. IFN-A/IL-2 LIPO/POLYMELVAC
- (UMLS (NCI) C0796454) Interferon Alfa/Interleukin-2 Liposome/Polyvalent Melanoma Vaccine;
=Therapeutic or Preventive Procedure |
- 213. Idiopathic Aplastic Anemia
- (UMLS (NCI) C0348890) =Disease or Syndrome
| - 263. IFN-A/IL-2/LAK
- (UMLS (NCI) C0338126) =Therapeutic or Preventive Procedure ;
|
- 214. Idiopathic Cardiomyopathy
- [A disease of the heart muscle or myocardium proper whose cause is unknown. ( NCI )] (UMLS (NCI) C0033141) =Disease or Syndrome ;
| - 264. IFN-A/IL-2/MOAB R24
- (UMLS (NCI) C0338150) =Therapeutic or Preventive Procedure
|
- 215. IDIOPATHIC CORNEAL EDEMA
- [ ] (UMLS (ICD9CM) C0155109) =Disease or Syndrome ;
| - 265. IFN-A/IL-2/TAX
- (UMLS (NCI) C0338259) =Therapeutic or Preventive Procedure
|
- 216. Idiopathic Cyst of Iris
- (UMLS (NCI) C0271120) =Finding ;
| - 266. IFN-A/IL-2/TIL
- (UMLS (NCI) C0338097) =Therapeutic or Preventive Procedure ;
|
- 217. IDIOPATHIC CYSTS
- [ ] (UMLS (ICD9CM) C0154927) =Disease or Syndrome ;
| - 267. IFN-A/IL-2/TMX
- (UMLS (NCI) C0338190) =Therapeutic or Preventive Procedure ;
|
- 218. Idiopathic Granulomatous Myositis
- (UMLS (NCI) C1334150) =Disease or Syndrome ;
| - 268. IFN-A/IL-2/TNF
- (UMLS (NCI) C0338153) =Therapeutic or Preventive Procedure
|
- 219. idiopathic hypercalcemia supravalvular aortic stenosis
- [ ] (UMLS (CSP) C0599641) =Disease or Syndrome ;
| - 269. IFN-A/L-ATRA
- (UMLS (NCI) C0796441) Interferon Alfa/Tretinoin Liposome =Therapeutic or Preventive Procedure ;
|
- 220. idiopathic hypereosinophilic syndrome
- [ ] (UMLS (CSP) C0206141) =Disease or Syndrome ;
| - 270. IFN-A/L-PAM/PRED
- (UMLS (NCI) C0338130) =Therapeutic or Preventive Procedure ;
|
- 221. idiopathic hyperlipemia
- [ ] (UMLS (CSP) C0598427) =Disease or Syndrome ;
| - 271. IFN-A/MEG/TMX
- (UMLS (NCI) C0338159) =Therapeutic or Preventive Procedure
|
- 222. idiopathic hypertrophic subaortic stenosis
- [ ] (UMLS (CSP) C0700053) =Disease or Syndrome
| - 272. IFN-A/MOAB CC49
- (UMLS (NCI) C0338180) =Therapeutic or Preventive Procedure
|
- 223. IDIOPATHIC MYOCARDITIS
- [ ] (UMLS (ICD9CM) C0155689) =Disease or Syndrome
| - 273. IFN-A/MOAB CC49/TAX
- (UMLS (NCI) C0338288) =Therapeutic or Preventive Procedure ;
|
- 224. Idiopathic normal pressure hydrocephalus (INPH)
- [ ] (UMLS (ICD9CM) C1955760) NORML PRESSURE HYDROCEPH;
=Disease or Syndrome | - 274. IFN-A/MP/MTX
- (UMLS (NCI) C0338125) =Therapeutic or Preventive Procedure ;
|
- 225. IDIOPATHIC OSTEOPOROSIS
- [ ] (UMLS (ICD9CM) C0158447) =Disease or Syndrome
| - 275. IFN-A/MP/MTX/PRED/VCR
- (UMLS (NCI) C0338168) =Therapeutic or Preventive Procedure
|
- 226. Idiopathic Pneumonia Syndrome
- [An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent. ( NCI )] (UMLS (NCI) C1504431) =Disease or Syndrome ;
| - 276. IFN-A/Poly ICLC
- (UMLS (NCI) C0338131) =Therapeutic or Preventive Procedure ;
|
- 227. idiopathic respiratory distress of newborn
- [a condition of the newborn marked by dyspnea with cyanosis, heralded by such prodromal signs as dilatation of the alae nasi, expiratory grunt, and retraction of the suprasternal notch or costal margins, most frequently occurring in premature infants, children of diabetic mothers, and infants delivered by cesarean section, and sometimes with no apparent predisposing cause. ( CSP )] (UMLS (CSP) C0035220) =Disease or Syndrome ;
=syndrome;
congenital respiratory disorder | - 277. IFN-A/PRED
- (UMLS (NCI) C0338090) =Therapeutic or Preventive Procedure
|
- 228. IDIOPATHIC SCOLIOSIS
- (UMLS (ICD9CM) C0036440) =Anatomical Abnormality ;
| - 278. IFN-A/PXM
- (UMLS (NCI) C0338116) =Therapeutic or Preventive Procedure ;
|
- 229. Idiopathic Thrombocytopenic Purpura
- [Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases IMMUNOGLOBULIN G autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms. ( MSH )] (UMLS (NCI) C0043117) =Disease or Syndrome ;
=autoimmune disease;
HEMORRHAGIC COND NOS;
Purpura, Thrombocytopenic;
| - 279. IFN-A/RIT
- (UMLS (NCI) C0678012) =Therapeutic or Preventive Procedure
|
- 230. IDIOPATHIC URTICARIA
- [ ] (UMLS (ICD9CM) C0157741) =Disease or Syndrome
| - 280. IFN-A/TMX
- (UMLS (NCI) C0338092) =Therapeutic or Preventive Procedure
|
- 231. Idiosyncratic alcohol intoxication
- (UMLS (ICD9CM) C0001950) =Mental or Behavioral Dysfunction ;
| - 281. IFN-A/TOR
- (UMLS (NCI) C0796500) Interferon Alfa/Toremifene;
=Therapeutic or Preventive Procedure ;
|
- 232. Idiotype
- [unique, genetically controlled determinants present on antibodies whose specificity is limited to a single group of proteins such as another antibody molecule or an individual myeloma protein; the idiotype appears to represent the antigenicity of the antigen binding site of the antibody and to be genetically codetermined with it; the idiotypic determinants have been precisely located to the immunoglobulin variable region of both immunoglobin polypeptide chains. ( CSP )] (UMLS (NCI) C0021013) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=[IM500] IMMUNOGLOBULINS;
| - 282. IFN-A/VBL
- (UMLS (NCI) C0338084) =Therapeutic or Preventive Procedure
|
- 233. idiotype regulatory network
- [ ] (UMLS (CSP) C0597882) =Molecular Function ;
| - 283. IFN-A/ZDV
- (UMLS (NCI) C0338111) =Therapeutic or Preventive Procedure ;
|
- 234. Idioventricular Rhythm
- [Relating to or affecting the cardiac ventricles alone. ( NCI )] (UMLS (NCI) C0700363) =Pathologic Function
| - 284. IFN-Alpha-Like
- [Encoded by human IFNW1 Gene (IFN Alpha, Beta, Delta Family), secreted 195-amino acid 22 kD (precursor) Interferon Omega 1, a type I interferon protein containing the interferon alpha/beta domain, appears to regulate antiviral defense, cell growth, and immune activation. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0083028) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 235. Idle
- (UMLS (HL7) C1550006) =Idea or Concept =Equipment state;
| - 285. IFN-B/IFN-G
- (UMLS (NCI) C0278889) =Therapeutic or Preventive Procedure
|
- 236. IDN5109
- (UMLS (NCI) C0912382) =Organic Chemical; Pharmacologic Substance
| - 286. IFN-B/IL-2
- (UMLS (NCI) C0278888) =Therapeutic or Preventive Procedure
|
- 237. iduronidase deficiency disease
- [autosomal recessive systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase and characterized by progressive physical deterioration with urinary excretion of dermatan sulfate and heparan sulfate; there are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler's syndrome, Hurler-Scheie syndrome and Scheie's syndrome (formerly mucopolysaccharidosis V); symptoms may include dwarfism, hepatosplenomegaly, gargoyle-like facies, corneal clouding, cardiac complications, and noisy breathing. ( CSP )] (UMLS (CSP) C0023786) =Disease or Syndrome =Collagen Diseases;
Mucopolysaccharidoses;
enzyme deficiency;
| - 287. IFN-B/ZDV
- (UMLS (NCI) C0279257) =Therapeutic or Preventive Procedure
|
- 238. IDV
- [A drug that interferes with the ability of a virus to make copies of itself. ( NCI )] (UMLS (NCI) C0376637) =Organic Chemical; Pharmacologic Substance ;
=[AM800] ANTIVIRALS;
protease inhibitor;
pyridine;
=INDINAVIR SULFATE;
| - 288. IFN-G/IL-2
- (UMLS (NCI) C0278666) =Therapeutic or Preventive Procedure
|
- 239. IE12
- [ ] (UMLS (CSP) C0599803) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 289. IFN-G/IL-2/L-PAM/TNF
- (UMLS (NCI) C0281542) =Therapeutic or Preventive Procedure
|
- 240. IETF RFC 1766
- [Language identifiers as defined by IETF RFC 1766: Tags for the Identification of Languages, or its successor on the IETF Standards Track. The biblio ref for RFC 1766 is: IETF (Internet Engineering Task Force), RFC 1766: Tag ( HL7V3.0 )] (UMLS (HL7) C1553867) =Intellectual Product =CodeSystem;
| - 290. IFN-G/IL-2/TIL
- (UMLS (NCI) C0280887) =Therapeutic or Preventive Procedure
|
- 241. If
- (UMLS (NCI) C0750557) =Qualitative Concept
| - 291. IFN-G/L-PAM/TNF
- (UMLS (NCI) C0281301) =Therapeutic or Preventive Procedure
|
- 242. IFA/IL-12/MART-1
- (UMLS (NCI) C0281755) =Therapeutic or Preventive Procedure
| - 292. IFN-G/LEV
- (UMLS (NCI) C0279454) =Therapeutic or Preventive Procedure
|
- 243. IFA/IL-12/TYRP
- (UMLS (NCI) C0677820) =Therapeutic or Preventive Procedure
| - 293. IFN-G/M-CSF
- (UMLS (NCI) C0280978) =Therapeutic or Preventive Procedure
|
- 244. IFA/IL-2/TRP-1
- (UMLS (NCI) C0677821) =Therapeutic or Preventive Procedure
| - 294. IFN-G/MOAB CC49
- (UMLS (NCI) C0338298) =Therapeutic or Preventive Procedure
|
- 245. IFA/IL-2/TYRP
- (UMLS (NCI) C0677817) =Therapeutic or Preventive Procedure
| - 295. IFN-G/TNF
- (UMLS (NCI) C0280507) =Therapeutic or Preventive Procedure ;
|
- 246. IFA/MART-1
- (UMLS (NCI) C0281720) =Therapeutic or Preventive Procedure
| - 296. IFN-Gamma Receptor
- [Expressed in monocytes, lymphocytes, and placenta, human Interferon Gamma Receptor Complex (Type II Cytokine Family Receptor) is a Ser/Thr phosphorylated type I membrane protein heteromeric receptor for IFN-gamma, composed of IFNGR1 and IFNGR2, that activates macrophages in host defenses. In mediating innate immune responses to viral infection, binding of IFN-gamma activates JAK kinases leading to tyrosine phosphorylation of STAT1 and STAT2. IFNGR1 constitutes the receptor ligand-binding alpha chain while the integral accessory factor IFNGR2 is required for signal transduction and may interact with GAF, JAK1, and/or JAK2. (NCI) ( NCI )] (UMLS (NCI) C1334197) Interferon Gamma Receptor Complex;
=Amino Acid, Peptide, or Protein; Receptor ;
|
- 247. IFA/p946
- (UMLS (NCI) C0796297) Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine =Therapeutic or Preventive Procedure ;
| - 297. IFN-gamma-Inducing Factor
- [cytokine which resembles interleukin 1 structurally and interleukin 12 functionally; enhances cytotoxic activity of NK cells and CTLs; appears to play a role both as neuroimmunomodulator and in the induction of mucosal immunity. ( CSP )] (UMLS (NCI) C0383327) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
=Cytokine;
|
- 248. IFA/p946/Tet p
- (UMLS (NCI) C0796299) Incomplete Freund's Adjuvant/Peptide 946 Melanoma Vaccine/Tetanus Peptide Melanoma Vaccine;
Incomplete Freund's Adjuvant/Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine;
=Therapeutic or Preventive Procedure ;
| - 298. IFNa
- [major interferon produced by virus-exposed leukocytes; has antiviral activity and activates NK cells; used in the treatment of hairy cell leukemia and other neoplasms. ( CSP )] (UMLS (CSP) C0002199) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 249. IFA/VHL peptide
- (UMLS (NCI) C0796337) Incomplete Freund's Adjuvant/Von Hippel-Lindau Peptide Vaccine;
=Therapeutic or Preventive Procedure | - 299. IFNA13
- [This gene plays a role in signal transduction and is involved in the immune response. ( NCI )] (UMLS (NCI) C1334079) IFNA13 Gene;
Interferon, Alpha 13 Gene;
=Gene or Genome ◊ [Encoded by human IFNA13 Gene (IFN Alpha Family) and expressed by macrophages, secreted 189-amino acid 21.7 kD (precursor) Interferon Alpha 13 contains the interferon alpha/beta domain and appears to regulate antiviral defense, cell growth, and immune activation; it stimulates the production of a protein kinase and an oligoadenylate synthetase. Interferons Alpha-13 and Alpha-1 have identical protein sequence. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1334193) IFNA13 Protein; Interferon Alpha 13; Interferon Alpha-D; LeIF D Amino Acid, Peptide, or Protein; Immunologic Factor |
- 250. IFF/MTP-PE Liposome
- (UMLS (NCI) C0281211) =Therapeutic or Preventive Procedure
| - 300. IFNA2
- [Encoded by human INFA2 Gene (IFN Alpha Family) and expressed by macrophages, secreted 188-amino acid 21.6 kD (precursor) Interferon Alpha 2 contains the interferon alpha/beta domain, exhibits interferon-alpha/beta receptor ligand activity, and appears to regulate antiviral defense, cell growth, and immune activation. It stimulates the production of a protein kinase and an oligoadenylate synthetase. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0535872) =Amino Acid, Peptide, or Protein; Immunologic Factor
|
home
